OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis
Angela Meggiolaro, Monica Sañé Schepisi, Sara Farina, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 12, pp. 1831-1841
Open Access | Times Cited: 17
Angela Meggiolaro, Monica Sañé Schepisi, Sara Farina, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 12, pp. 1831-1841
Open Access | Times Cited: 17
Showing 17 citing articles:
A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529)
Hassen Mohammed, Dan Duy Pham-Tran, Zi Yi Michelle Yeoh, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 224-224
Open Access | Times Cited: 34
Hassen Mohammed, Dan Duy Pham-Tran, Zi Yi Michelle Yeoh, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 224-224
Open Access | Times Cited: 34
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
Alessio Cortellini, Josep Tabernero, Uma Mukherjee, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 4, pp. 335-346
Open Access | Times Cited: 24
Alessio Cortellini, Josep Tabernero, Uma Mukherjee, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 4, pp. 335-346
Open Access | Times Cited: 24
Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
Nicholas Magazine, Tianyi Zhang, Anang D. Bungwon, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 3, pp. 214-226
Open Access | Times Cited: 8
Nicholas Magazine, Tianyi Zhang, Anang D. Bungwon, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 3, pp. 214-226
Open Access | Times Cited: 8
Durability of COVID-19 vaccine and infection induced immunity: A systematic review and meta-regression analysis
Mia Moore, Larissa Anderson, Joshua T. Schiffer, et al.
Vaccine (2025) Vol. 54, pp. 126966-126966
Closed Access
Mia Moore, Larissa Anderson, Joshua T. Schiffer, et al.
Vaccine (2025) Vol. 54, pp. 126966-126966
Closed Access
Incidence and Determinants of Symptomatic and Asymptomatic SARS-CoV-2 Breakthrough Infections After Booster Dose in a Large European Multicentric Cohort of Health Workers-ORCHESTRA Project
Stefano Porru, Maria Grazia Lourdes Monaco, Gianluca Spiteri, et al.
Journal of Epidemiology and Global Health (2023) Vol. 13, Iss. 3, pp. 577-588
Open Access | Times Cited: 14
Stefano Porru, Maria Grazia Lourdes Monaco, Gianluca Spiteri, et al.
Journal of Epidemiology and Global Health (2023) Vol. 13, Iss. 3, pp. 577-588
Open Access | Times Cited: 14
Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis
Obaidur Rahman, Taro Kamigaki, Moe Moe Thandar, et al.
BMJ Open (2023) Vol. 13, Iss. 12, pp. e076892-e076892
Open Access | Times Cited: 14
Obaidur Rahman, Taro Kamigaki, Moe Moe Thandar, et al.
BMJ Open (2023) Vol. 13, Iss. 12, pp. e076892-e076892
Open Access | Times Cited: 14
Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population
Loredana Frasca, Giuseppe Ocone, Raffaella Palazzo
Pathogens (2023) Vol. 12, Iss. 2, pp. 233-233
Open Access | Times Cited: 10
Loredana Frasca, Giuseppe Ocone, Raffaella Palazzo
Pathogens (2023) Vol. 12, Iss. 2, pp. 233-233
Open Access | Times Cited: 10
COVID-19 Vaccination Effectiveness in the General Population of an Italian Province: Two Years of Follow-Up
Annalisa Rosso, Maria Elena Flacco, Graziella Soldato, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1325-1325
Open Access | Times Cited: 10
Annalisa Rosso, Maria Elena Flacco, Graziella Soldato, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1325-1325
Open Access | Times Cited: 10
Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort
Ida Laake, Siri N. Skodvin, Kristine Blix, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 11, pp. 1924-1933
Open Access | Times Cited: 15
Ida Laake, Siri N. Skodvin, Kristine Blix, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 11, pp. 1924-1933
Open Access | Times Cited: 15
Improving Nasal Protection for Preventing SARS-CoV-2 Infection
Riccardo Nocini, Brandon Michael Henry, Camilla Mattiuzzi, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2966-2966
Open Access | Times Cited: 12
Riccardo Nocini, Brandon Michael Henry, Camilla Mattiuzzi, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2966-2966
Open Access | Times Cited: 12
The COVID-19 Pandemic—A Potential Role for Antivirals in Mitigating Pandemics
Gabriele Neumann, Yoshihiro Kawaoka
Viruses (2023) Vol. 15, Iss. 2, pp. 303-303
Open Access | Times Cited: 3
Gabriele Neumann, Yoshihiro Kawaoka
Viruses (2023) Vol. 15, Iss. 2, pp. 303-303
Open Access | Times Cited: 3
The Scabbard of Excalibur: An Allegory on the Role of an Efficient and Effective Healthcare System under Universal Health Coverage during the Pandemic Response
Hiroyuki Noda
Healthcare (2024) Vol. 12, Iss. 10, pp. 979-979
Open Access
Hiroyuki Noda
Healthcare (2024) Vol. 12, Iss. 10, pp. 979-979
Open Access
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants
Kristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Kristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection
Huiling Zheng, Shenggen Wu, Chen Wu, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access
Huiling Zheng, Shenggen Wu, Chen Wu, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access
Unpredicted protective function of Fc-mediated inhibitory antibodies for HIV and SARS-CoV-2 vaccines
Liyun Lin, Pierre Gantner, Shuang Li, et al.
The Journal of Infectious Diseases (2024)
Open Access
Liyun Lin, Pierre Gantner, Shuang Li, et al.
The Journal of Infectious Diseases (2024)
Open Access
Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
Nicholas Magazine, Tianyi Zhang, Anang D. Bungwon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Nicholas Magazine, Tianyi Zhang, Anang D. Bungwon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein
Kristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Kristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
